Sökning: WFRF:(Hellberg Christel) >
Development of a co...
-
Bohm-Starke, NinaKarolinska Institutet,Division of Obstetrics and Gynecology, Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, 171 77 Stockholm, Sweden
(författare)
Development of a core outcome set for treatment studies for provoked vestibulodynia.
- Artikel/kapitelEngelska2024
Förlag, utgivningsår, omfång ...
-
Oxford University Press,2024
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:mau-66697
-
https://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-66697URI
-
https://doi.org/10.1093/jsxmed/qdae035DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:155269270URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
BACKGROUND: There is an inconsistency in treatment outcomes used in clinical trials for provoked vestibulodynia (PVD), which makes it impossible to compare the effects of different interventions.AIM: In this study, we completed the first step in creating a core outcome set (COS), defining what outcomes should be measured in clinical trials for PVD.METHODS: Identification of outcomes used in studies was done by extracting data from clinical trials in a recently published systematic review and via review of clinical trials for PVD registered on ClinicalTrials.gov. The COS process consisted of 2 rounds of Delphi surveys and a consensus meeting, during which the final COS was decided through a modified nominal group technique.OUTCOMES: Consensus on what outcomes to include in a COS for PVD.RESULTS: Forty scientific articles and 92 study protocols were reviewed for outcomes. Of those, 36 articles and 25 protocols were eligible, resulting in 402 outcomes, which were then categorized into 63 unique outcomes. Participants consisted of patients, relatives/partners of patients, health care professionals, and researchers. Out of 463 who registered for participation, 319 and 213 responded to the first and second surveys, respectively. The consensus meeting consisted of 18 members and resulted in 6 outcomes for the COS to be measured in all treatment trials regardless of intervention: insertional pain (nonsexual), insertional pain (sexual), provoked vulvar pain by pressure/contact, pain-related interference on one's life, pain interference on sexual life, and sexual function.CLINICAL IMPLICATIONS: Critical outcomes to be measured in clinical trials will allow for accurate comparison of outcomes across treatment interventions and provide solid treatment recommendations.STRENGTHS AND LIMITATIONS: The major strengths of the study are the adherence to methodological recommendations and the intentional focus on aspects of diversity of participating stakeholders (eg, status such as patients with lived experience and researchers, inclusiveness with respect to sexual identity), the latter of which will allow for broader application and relevance of the COS. Among the limitations of the study are the low rate of participants outside North America and Europe and the lower response rate (about 50%) for the second Delphi survey.CONCLUSION: In this international project, patients, health care professionals, and researchers have decided what critical outcomes are to be used in future clinical trials for PVD. Before the COS can be fully implemented, there is also a need to decide on how and preferably when the outcomes should be measured.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Pukall, CarolineDepartment of Psychology, Queen’s University, Kingston, ON K7L 3N6, Canada
(författare)
-
Österberg, MarieSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, 102 33, Sweden
(författare)
-
Ahlberg, MariaSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, 102 33, Sweden
(författare)
-
Jonsson, Ann KristineSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, 102 33, Sweden
(författare)
-
Tranæus, SofiaMalmö universitet,Odontologiska fakulteten (OD),Swedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, 102 33, Sweden(Swepub:mau)af4429
(författare)
-
Kempe, SusannaSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, 102 33, Sweden
(författare)
-
Hellberg, ChristelSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, 102 33, Sweden
(författare)
-
Karolinska InstitutetDivision of Obstetrics and Gynecology, Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, 171 77 Stockholm, Sweden
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of Sexual Medicine: Oxford University Press21:6, s. 556-5651743-60951743-6109
Internetlänk
Hitta via bibliotek
Till lärosätets databas